{"product_id":"holdings-business-model-canvas","title":"FUJIFILM Holdings Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Model Canvas: value creation across healthcare, imaging and materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind FUJIFILM Holdings with our Business Model Canvas—three concise sections preview how the company creates value across healthcare, imaging, and materials. Dive deeper with the complete canvas to access customer segments, revenue mechanics, and strategic risks—perfect for investors and strategists seeking a ready-to-use, actionable analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with hospitals and clinics enable FUJIFILM to pilot medical systems, imaging workflows and AI diagnostics in real settings, supporting clinical validation and creating reference sites across 30+ countries; multi-year agreements (common in FUJIFILM’s healthcare deals) align product roadmaps with provider needs and revenue cycles, while continuous feedback loops improve usability, uptime and regulatory readiness for market rollouts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma\/Biotech and CDMO Clients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnerships with pharma\/biotech and CDMO clients cover therapeutic development, GMP manufacturing, and diagnostics integration, with co-development and contract services increasing pipeline visibility and securing multi-year capacity commitments; Fujifilm reported over 2.5 trillion yen consolidated sales in FY2024, with life-science investments driving capacity scaling. Joint quality and tech-transfer frameworks cut time-to-market, while structured data-sharing deepens trust and expands multimodal scope.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUniversities and Research Institutes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAcademic ties fuel Fujifilm advances in materials, optics and life sciences, supported by R\u0026amp;D spending of about ¥90 billion in FY2023 and continued 2024 collaborations. Sponsored research and consortia accelerate IP generation and validation, producing patents and peer-reviewed papers that strengthen regulatory positioning. Talent pipelines and shared labs de-risk early-stage science by enabling rapid translational work and scale-up.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSemiconductor\/Display Ecosystem Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAlliances with chip and panel makers guide FUJIFILM’s specifications for high-functional materials, feeding into joint roadmaps that track node shrinks such as TSMC’s move toward 2nm (planned 2025) and emerging substrates for advanced displays. Process co-optimization with foundries and OSATs ensures compatibility and measurable yield gains in prototyping phases. Supplier partnerships lock in critical precursors and pharma-grade purity controls to meet volume ramp timelines.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003epartner-focus: co-roadmaps with foundries (2nm era)\u003c\/li\u003e\n\u003cli\u003ematerials-priority: high-purity precursors for yield\u003c\/li\u003e\n\u003cli\u003eprocess: co-optimization reduces integration risk\u003c\/li\u003e\n\u003cli\u003esupply-security: strategic contracts for critical chemicals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIT\/Cloud and Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCloud providers and PACS\/VNA integrators deliver secure imaging platforms and data services that supported a 62% healthcare cloud adoption rate in 2024, enabling Fujifilm to offer scalable teleradiology and archive solutions with enterprise-grade security and uptime.\u003c\/p\u003e\n\u003cp\u003eGlobal distributors extend Fujifilm reach for medical and imaging equipment across regions, local service partners accelerate installations and SLA response times, and interoperability partners ensure standards-based DICOM\/HL7 integrations for seamless workflows.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCloud\/PACS: secure imaging \u0026amp; archiving\u003c\/li\u003e\n\u003cli\u003eDistribution: global market access\u003c\/li\u003e\n\u003cli\u003eLocal service: faster installs \u0026amp; SLA coverage\u003c\/li\u003e\n\u003cli\u003eInteroperability: DICOM\/HL7 standards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic partnerships accelerate co-development, scale capacity and commercial rollout in healthcare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrategic partnerships with hospitals, pharma\/CDMOs, academia, chip suppliers, cloud providers and distributors enable FUJIFILM to co-develop products, secure capacity and scale commercial rollouts. FY2024 consolidated sales ~¥2.5T and R\u0026amp;D ~¥90B (FY2023) underpin collaborations. 62% healthcare cloud adoption in 2024 accelerates teleradiology. Multi-year contracts and supply agreements reduce time-to-market and integration risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 KPI \/ Data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003eClinical pilots, reference sites\u003c\/td\u003e\n\u003ctd\u003e30+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\/CDMO\u003c\/td\u003e\n\u003ctd\u003eGMP capacity, tech-transfer\u003c\/td\u003e\n\u003ctd\u003eMulti-year contracts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinance\/R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003eInvestment\u003c\/td\u003e\n\u003ctd\u003eSales ¥2.5T; R\u0026amp;D ¥90B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud\u003c\/td\u003e\n\u003ctd\u003eImaging\/archiving\u003c\/td\u003e\n\u003ctd\u003e62% adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive Business Model Canvas for FUJIFILM Holdings outlining customer segments, channels, value propositions, revenue streams, key resources, partners, activities and cost structure; includes competitive advantages and linked SWOT analysis, ideal for investor presentations and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas for FUJIFILM Holdings that condenses diversified healthcare, imaging, and document solutions into a one-page snapshot—ideal for teams to quickly identify strategic gaps, brainstorm growth opportunities, and save hours on structuring board-ready deliverables.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCross-Domain R\u0026amp;D and Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCore R\u0026amp;D spans image processing, AI, optics, chemistry and biomaterials, feeding FUJIFILM’s translational pipeline that converts lab breakthroughs into certified products; consolidated revenue was about ¥2.6 trillion in FY2023 (year ended Mar 2024). The group balances a portfolio across healthcare, materials and imaging to spread risk, with healthcare growing as a major segment, and maintains continuous IP filing—holding over 40,000 patents globally—to protect differentiation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Manufacturing and Quality\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHigh-spec production for diagnostic systems, optical lenses, membranes and advanced coatings drives Fujifilm’s manufacturing footprint, with 2024 operations focused on scale-up for healthcare and CDMO projects. GMP and ISO-compliant facilities support regulatory supply chains. Rigorous yield management and metrology programs ensure consistency at scale. Supplier qualification processes maintain material integrity across global sourcing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory, Clinical, and Safety Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnd-to-end compliance spans FDA, EMA, PMDA and other global regimes, ensuring alignment with three major regulatory authorities and ICH\/IMDRF frameworks. Clinical studies validate efficacy and safety for devices and pharmaceuticals through randomized and pivotal trials. Vigilance systems continuously monitor post-market performance via adverse event reporting and signal detection. Documentation and audits sustain approvals and tender eligibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Sales, Service, and Lifecycle Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobal sales combine direct and partner-led channels into hospitals, labs, semiconductor fabs, and commercial print houses, supported by FUJIFILM’s field network operating across 70+ countries (2024) to reach clinical and industrial buyers.\u003c\/p\u003e\n\u003cp\u003eInstallation, calibration, and preventative maintenance by over 1,000 trained engineers sustain uptime and service-level commitments, while training and certification programs drive faster user adoption and compliance.\u003c\/p\u003e\n\u003cp\u003eRefurbishment, upgrade, and trade-in programs extend asset life, improve ROIC for customers, and feed recurring service revenue streams in FUJIFILM’s lifecycle strategy.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect + partner sales into hospitals, labs, fabs, print houses\u003c\/li\u003e\n\u003cli\u003eInstallation, calibration, preventative maintenance to maximize uptime\u003c\/li\u003e\n\u003cli\u003eTraining and certification to boost adoption and compliance\u003c\/li\u003e\n\u003cli\u003eRefurb, upgrade, trade-in to extend product life and recurring revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Portfolio Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDual-sourcing and inventory strategies reduce disruption risk across Fujifilm’s diversified segments, supporting long-horizon capex planning that aligns capacity and product-mix shifts; Fujifilm reported consolidated revenue of about 2.7 trillion JPY in FY2023 (year ended Mar 2024), guiding capex to match growth areas.\u003c\/p\u003e\n\u003cp\u003eM\u0026amp;A, licensing and divestitures are used to refine the portfolio while ESG and stringent safety controls govern operations and suppliers, with Fujifilm targeting net-zero GHG by 2050 and interim 2030 sustainability goals.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDual-sourcing: risk mitigation\u003c\/li\u003e\n\u003cli\u003eLong-horizon capex: capacity + mix alignment\u003c\/li\u003e\n\u003cli\u003eM\u0026amp;A\/licensing\/divestitures: portfolio refinement\u003c\/li\u003e\n\u003cli\u003eESG\/safety: supplier and operations governance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal imaging \u0026amp; healthcare innovator — 40,000+ patents, ¥2.6–2.7T revenue, net-zero 2050\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFUJIFILM’s key activities center on R\u0026amp;D in imaging, AI, optics, chemistry and biomaterials, high-spec manufacturing (GMP\/ISO), global regulatory\/compliance, and integrated sales\/service networks that support healthcare, materials and imaging businesses; consolidated revenue ~¥2.6–2.7 trillion (FY2023). The group protects IP (\u0026gt;40,000 patents), operates in 70+ countries, employs 1,000+ service engineers, and targets net-zero GHG by 2050.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated revenue (FY2023)\u003c\/td\u003e\n\u003ctd\u003e¥2.6–2.7 trillion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;40,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCountries of operation (2024)\u003c\/td\u003e\n\u003ctd\u003e70+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService engineers\u003c\/td\u003e\n\u003ctd\u003e1,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet-zero target\u003c\/td\u003e\n\u003ctd\u003e2050\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual FUJIFILM Holdings Business Model Canvas, not a mockup or marketing sample. When you purchase, you'll receive this exact file with all content and pages included. It's ready to edit, present, or share in the same professional format. No surprises—what you see is what you get.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674891829625,"sku":"holdings-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/holdings-business-model-canvas.png?v=1755797649","url":"https:\/\/portersfiveforce.com\/products\/holdings-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}